BELFAST nonagenarians: Nature or nurture? Immunological, cardiovascular and genetic factors

Immunity and Ageing

Volumn 7, Issue , 2010, Pages

  Rea, I M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CARDIOVASCULAR RISK; CELLULAR IMMUNITY; ELDERLY CARE; HEREDITY; HUMAN; INNATE IMMUNITY; NATURAL KILLER CELL; NUTRITION; PRIORITY JOURNAL; REVIEW;

EID: 77952694257     PISSN: 17424933     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4933-7-6     Document Type: Review

References (77)

1. Rea IM, McMaster D, Woodside JV, Young IS, Archbold GPR, Linton T, Lennox S, McNulty H, Harmon DL, Whitehead AS. Community living nonagenarians in Northern Ireland have lower plasma homocysteine but similar methylenetetrahydrofolate reductase thermolabile genotype prevalence compared to 70-89 year old subjects. Atherosclerosis 2000, 149:207-214. 10.1016/S0021-9150(99)00417-7, 10704633.
2. Rea IM, Myint PK, Mueller H, Murphy A, Archbold GP, McNulty H, Patterson CC. Nature or nurture; BMI and blood pressure at 90. Findings from the Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST). Age (Dordr) 31(4):261-267. 2813048, 19496022.
3. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician". Psychiatr Res 1975, 3:189-198.
4. Rea IM, Gillen S, Clarke E. Anthropometric measurements from a cross-sectional survey of community dwelling subjects aged over 90 years of age. Eur J Clin Nutr 1997, 51:102-106. 10.1038/sj.ejcn.1600370, 9049569.
5. Rea IM. Age and Sex changes in Neutrophil Function. Ageing; Immunology and Infectious Disease 1988, 1:121-130.
6. Wenisch C, Patruta S, Daxböck F, Krause R, Hörl W. Effect of age on human neutrophil function. J Leukoc Biol 2000, 67:40-45.
7. Alonso-Fernández P, Puerto M, Maté I, Ribera JM, de la Fuente M. Neutrophils of centenarians show function levels similar to those of young adults. J Am Geriatr Soc 2008, 56:2244-2251. 10.1111/j.1532-5415.2008.02018.x, 19093924.
8. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, Lord JM, Shaw AC. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009, 30:325-333. 10.1016/j.it.2009.05.004, 19541535.
9. Armstrong ME, Alexander HD, Ritchie JL. Age-related alterations in basal expression and in vitro, tumour necrosis factor alpha mediated, upregulation of CD11b. Gerontology 2001, 47:180-185. 10.1159/000052795, 11408721.
10. Niwa Y, Kasama T, Miyachi Y, Kanoh T. Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging:-Neutrophils of centenarians show function levels similar to those of young adults. Life Sci 1989, 44:1655-1664. 10.1016/0024-3205(89)90482-7, 2733545.
11. Mocchegiani E, Giacconi R, Cipriano C, Malavolta M. NK and NKT Cells in Aging and Longevity: Role of Zinc and Metallothioneins. J Clin Immunol 2009, 29(Sp I):416-425. 10.1007/s10875-009-9298-4, 19408107.
12. Kaszubowska L, Dettlaff-Pokora A, Hak L, Szarynska M, Ryba M, Mysliwska J, Mysliwski A. Successful ageing of nonagenarians is related to the sensitivity of NK cells to activation. J Physiol Pharmacol 2008, 59(Suppl 9):187-199.
13. Dubey DP, Husain Z, Levitan E, Zurakowski D, Mirza N, Younes S, Coronell C, Yunis D, Yunis EJ. The MHC influences NK and NKT cell functions associated with immune abnormalities and lifespan. Mech Ageing Dev 2000, 113:117-134. 10.1016/S0047-6374(99)00102-5, 10708259.
14. Miyaji C, Watanabe H, Minagawa M, Toma H, Kawamura T, Nohara Y, Nozaki H, Sato Y, Abo T. Numerical and functional characteristics of lymphocyte subsets in centenarians. J Clin Immunol 1997, 5:420-429.
15. Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, Marcato A, Passeri G, Ortolani C, Forti E. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 1993, 82:2767-2773.
16. McNerlan SE, Rea IM, Alexander HD, Morris TC. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging. J Clin Immunol 1998, 18:31-38. 10.1023/A:1023283719877, 9475351.
17. Peralbo E, Alonso C, Solana R. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing. Exp Gerontol 2007, 42:703-708. Epub 2007 May 21., 10.1016/j.exger.2007.05.002, 17604928.
18. Mariani E, Ravaglia G, Forti P, Meneghetti A, Tarozzi A, Maioli F, Boschi F, Facchini A. Nutrition and NK cell mediated immunity in centenarians. Immunology Letters 1997, 56(Part 2):383.
19. Maxwell LD, Ross OA, Curran MD, Rea IM, Middleton D. Investigation of KIR diversity in immunosenescence and longevity within the Irish population. Exp Gerontol 2004, 39:1223-1232. 10.1016/j.exger.2004.05.003, 15288696.
20. Rea IM, Maxwell LD, Ross OA, McNerlan SE, Alexander HD. Pro-inflammatory and anti-inflammatory cytokines track with KIR haplotypes A and B in octo/nonagenarian subjects. Clin Immunol 2005, 115(Suppl 1):S202.
21. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000, 908:244-254.
22. Rea IM, Stewart M, Campbell P, Alexander HD, Crockard AD, Morris TCM. Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology 1996, 42:69-78. 10.1159/000213775, 9138976.
23. McNerlan SE, Alexander HD, Rea IM. Age-related reference intervals for lymphocyte subsets in whole blood of healthy individuals. Scand J Clin Lab Invest 1999, 59:89-92. 10.1080/00365519950185805, 10353321.
24. Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM, Goronzy JJ. T cell subset-specific susceptibility to aging. Clin Immunol 2008, 127:107-118. 10.1016/j.clim.2007.12.002, 2435295, 18222733.
25. Fock RA, Blatt SL, Beutler B, Pereira J, Tsujita M, de Barros FE, Borelli P. Study of lymphocyte subpopulations in bone marrow in a model of protein-energy malnutrition. Nutrition 2009,
26. Lehtonen L, Eskola J, Vainio O, Lehtonen A. Changes in lymphocyte subsets and immune competence in very advanced age. J Gerontol 1990, 45:M108-12.
27. Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, Telera A, Lucchini G, Passeri G, Monti D, Franceschi C, Passeri M. The immune system in extreme longevity. Exp Gerontol 2008, 43:61-65. 10.1016/j.exger.2007.06.008, 17870272.
28. Yan J, Greer JM, Hull R, O'Sullivan JD, Henderson RD, Read SJ, McCombe PA. The effect of ageing on human lymphocyte subsets: comparison of males and females. Immunity & Ageing 2010, 7(4):1-10.
29. Rea IM, Alexander HD, Crockard AD, Morris TC. CD4 lymphopenia in very elderly people. Lancet 1996, 347:328-329. Erratum in: Lancet 1996, 347:914..
30. Belmin J, Ortega MN, Bruhat A, Mercadier A, Valensi P. CD4 lymphopenia in elderly patients. Lancet 1996, 347:911-912. 10.1016/S0140-6736(96)91400-2, 8622438.
31. Ogata K, Tamura H, Yokose N, Dan K, Nomura T. CD4 lymphopenia and risk of infection in immunogerontologically healthy elderly people. Lancet 1996, 347:1408. 10.1016/S0140-6736(96)91046-6, 8637360.
32. Wikby A, Månsson IA, Johansson B, Strindhall J, Nilsson SE. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 2008, 9:299-308. 10.1007/s10522-008-9138-6, 18369735.
33. Rea IM, Stewart M, Campbell P, Alexander HD, Morris TCM. CD4/CD8 ratio in human ageing. Br J Haematol 1996, 93(Suppl 1):190-191.
34. Strindhall J, Nilsson BO, Löfgren S, Ernerudh J, Pawelec G, Johansson B, Wikby A. No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 2007, 42:753-761. Epub 2007 May 21., 10.1016/j.exger.2007.05.001, 17606347.
35. McNerlan SE, Armstrong MA, Ross OA, Rea IM. Cytokine expression and production changes in Very Old Age. Handbook of Immunosenesence Basic understanding and clinical applications 2009, 40:771-785. Springer, Fulop T, Franceschi C, Hirokawa K, Pawelec G.
36. Rea IM, McNerlan SE, Alexander HD. Total serum IL-12 and IL-12p40, but not IL-12p70, are increased in the serum of older subjects; relationship to CD3(+)and NK subsets. Cytokine 2000, 12:156-159. 10.1006/cyto.1999.0537, 10671301.
37. Rea IM, Ross OA, Armstrong M, McNerlan S, Alexander DH, Curran MD, Middleton D. nterleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenarian subjects in the BELFAST study. Reciprocal effects on IL-6, soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech Ageing Dev 2003, 124:555-561. 10.1016/S0047-6374(03)00036-8, 12714267.
38. McNerlan SE, Rea IM, Alexander HD. A whole blood method for measurement of intracellular TNF-alpha, IFN-gamma and IL-2 expression in stimulated CD3+ lymphocytes: differences between young and elderly subjects. Exp Gerontol 2002, 37:227-234. 10.1016/S0531-5565(01)00188-7, 11772508.
39. Ross OA, Curran MD, Meenagh A, Williams F, Barnett YA, Middleton D, Rea IM. Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev 2003, 124:199-206. 10.1016/S0047-6374(02)00132-X, 12633940.
40. Rea IM, Candore G, Cavallone L, Olivieri F, Cardelli M, Franceschi C, Colonna-Romano G, Lio D, Ross OA, Caruso C. Longevity, in Cytokine Gene Polymorphisms in Multifactorial Conditions. 2006, 29:379-391. CRC Press, Vandenbroeck K.
41. Lio D, Marino V, Serauto A, Gioia V, Scola L, Crivello A, Forte GI, Colonna-Romano G, Candore G, Caruso C. Genotype frequencies of the +874T → A single nucleotide polymorphism in the first intron of the interferon-γ gene in a sample of Sicilian patients affected by tuberculosis. Eur J Immunogenet 2002, 29:371-374. 10.1046/j.1365-2370.2002.00327.x, 12358843.
42. Di Bona D, Vasto S, Capurso C, Christiansen L, Deiana L, Franceschi C, Hurme M, Mocchegiani E, Rea M, Lio D, Candore G, Caruso C. Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev 2009, 8:36-42. 10.1016/j.arr.2008.09.001, 18930842.
43. Hwang JH, Shim SS, Seok OS, Lee HY, Woo SK, Kim BH, Song HR, Lee JK, Park YK. Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow. J Korean Med Sci 2009, 24:547-554. 10.3346/jkms.2009.24.4.547, 2719209, 19654931.
44. Choi HM, Oh DH, Bang JS, Yang HI, Yoo MC, Kim KS. Differential effect of IL-1beta and TNF-alpha on the production of IL-6, IL-8 and PGE(2) in fibroblast-like synoviocytes and THP-1 macrophages. Rheumatol Int 2009,
45. Mena MP, Sacanella E, Vazquez-Agell M, Morales M, Fitó M, Escoda R, Serrano-Martínez M, Salas-Salvadó J, Benages N, Casas R, Lamuela-Raventós RM, Masanes F, Ros E, Estruch R. Inhibition of circulating immune cell activation: a molecular antiinflammatory effect of the Mediterranean diet. Am J Clin Nutr 2000, 89:248-56.
46. Camargo A, Ruano J, Fernandez JM, Parnell LD, Jimenez A, Santos-Gonzalez M, Mari C, Perez-Martinez P, Uceda M, Lopez-Miranda J, Perez-Jimenez F. Gene expression changes in mononuclear cells from patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genomics 2010, 11:253. 10.1186/1471-2164-11-253, 2874810, 20406432.
47. Corella D, González JI, Bulló M, Carrasco P, Portolés O, Díez-Espino J, Covas MI, Ruíz-Gutierrez V, Gómez-Gracia E, Arós F, Fiol M, Herrera MC, Santos JM, Sáez G, Lamuela R, Lahoz C, Vinyoles E, Ros E, Estruch R. Polymorphisms cyclooxygenase-2 -765 G > C and interleukin-6 -174 G > C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts. J Nutr 2009, 139:128-134.
48. Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB. Mediterrean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 2009, 119:1093-1100. 10.1161/CIRCULATIONAHA.108.816736, 2724471, 19221219.
49. Franceschi C, Bezrukov V, Blanché H, Bolund L, Christensen K, de Benedictis G, Deiana L, Gonos E, Hervonen A, Yang H, Jeune B, Kirkwood TB, Kristensen P, Leon A, Pelicci PG, Peltonen L, Poulain M, Rea IM, Remacle J, Robine JM, Schreiber S, Sikora E, Slagboom PE, Spazzafumo L, Stazi MA, Toussaint O, Vaupel JW. Genetics of healthy aging in Europe: the EU-integrated project GEHA (GEnetics of Healthy Aging). Ann N Y Acad Sci 2007, 1100:21-45. 10.1196/annals.1395.003, 17460163.
50. Hajjar H, Lackland DT, Cupples A, Lipsitz LA. Association between concurrent and remote blood pressure and disability in older adults. Hypertension 2007, 50:1026-1032. 10.1161/HYPERTENSIONAHA.107.097667, 2424316, 18025294.
51. Staessen J, Fagard R, Amery A. The relationship between body weight and blood pressure. J Hum Hypertens 1988, 2:207-217.
52. Ford ES, Giles WH, Dietz WH. Prevalence of the Metabolic Syndrome Among US Adults. Findings From the Third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359. 10.1001/jama.287.3.356, 11790215.
53. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease. Risk factor, paradox and impact of weight loss. J Am Coll Cardiol 2009, 53:1925-1932. 10.1016/j.jacc.2008.12.068, 19460605.
54. Williams GC. Pleiotropy, natural selection and the evolution of senescence. Evol Int J Org Evol 1957, 11:398-411.
55. Feng JH, McGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomised trials, implications for public health. J Hum Hypertens 2002, 16:761-770. 10.1038/sj.jhh.1001459, 12444537.
56. Whelton PK, Appel LJ, Espeland MA, Appelgate WB, Ettinger WH, Kostis JB, Kumanyika S, Lacy CR, Johnston KC, Folmar S, Cutler JA. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacological interventions in the elderly (TONE). Tone Collaborative Research Group JAMA 1998, 279:839-346.
57. Luft FC. Bad genes, good people, association, linkage, longevity and the prevention of cardiovascular disease. Clin Exp Pharmacol Physiol 1999, 26:576-579. 10.1046/j.1440-1681.1999.03080.x, 10405794.
58. Pearlman BL. The new cholesterol guidelines. Applying them in clinical practice. Postgrad Med 2002, 112:13-26. 10.3810/pgm.2002.08.1269, 12198751.
59. Viiri LE, Loimaala A, Nenonen A, Islam S, Vuori I, Karhunen PJ, Lehtimaki T. The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations. Atherosclerosis 2005, 179:167-174.
60. Elosua R, Ordovas JML, Cupples A, Fox CS, Polak JK, Wolf PA, D'Agostino RA, O'Donnell CJ. Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study. J. Lipid Res 2004, 45:1868-1875. 10.1194/jlr.M400114-JLR200, 15258198.
61. Volcik KA, Barkley RA, Hutchinson RG, Mosley TH, Heiss G, Sharrett AR, Ballantyne CM, Boerwinkle E. Apolipoprotein E Polymorphisms Predict Low Density Lipoprotein Cholesterol Levels and Carotid Artery Wall Thickness but Not Incident Coronary Heart Disease in 12,491 ARIC Study Participants. Am J Epidemiol 2006, 164:342-348. 10.1093/aje/kwj202, 16760224.
62. Rea IM, Mc Dowell I, McMaster D, Smye M, Stout R, Evans A. MONICA group (Belfast). Apolipoprotein E alleles in nonagenarian subjects in the Belfast Elderly Longitudinal Free-living Ageing Study (BELFAST). Monitoring of Cardiovascular trends study group. Mech Ageing Dev 2001, 122:1367-1372. 10.1016/S0047-6374(01)00278-0, 11470126.
63. Ilveskoski E, Perola M, Lehtimaki T, Laippala P, Savolainen V, Pajarinen J, Penttila A, Lalu KH, Mannikko A, Liesto KK, Koivula T, Karhunen PJ. Age-dependent association of apolipoprotein E genotype with coronary and aorticatherosclerosis in middle-aged men: an autopsy study. Circulation 1999, 6:608-613.
64. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644. 10.1038/359641a0, 1328889.
65. Kluijtmans LAJ, Heuvel PWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, den Heijer M, Trijbels FJM, Rozen R, Blom HJ. Molecular genetics analysis in mild hyperhomocysteinemia: a commonmutation in the methylenetetrahydrofolate reductase gene is a genetic riskfactor for cardiovascular disease. Am J Hum Genet 1996, 58:35-41. 1914961, 8554066.
66. Licastro F, Porcellini E, Caruso C, Lio D, Corder EH. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging 2007, 28:1637-1643. 10.1016/j.neurobiolaging.2006.07.007, 16930778.
67. Chuang YF, Hayden KM, Norton MC, Tschanz J, Breitner JC, Welsh-Bohmer KA, Zandi PP. Association between APOE epsilon4 allele and vascular dementia: The Cache County study. Dement Geriatr Cogn Disord 2010, 29:248-53. 10.1159/000285166, 20375505.
68. Schachter F, Faure-Delenauf L, Guenot F, Rouger H, Froguet P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the ApoE and ACE loci. Nature Genet 1994, 6:29-32. 10.1038/ng0194-29, 8136829.
69. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci 2001, 56:M75-78.
70. Galinsky D, Tysoe C, Brayne CE, Easton DF, Huppert FA, Dening TR, Paykel ES, Rubinsztein DC. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 1997, 129:177-183. 10.1016/S0021-9150(96)06027-3, 9105559.
71. Rea IM, Henry M, Cambien F, Whitehead AS. Apolipoprotein E gene (ApoE), Angiotensinogen Converting Enzyme gene (ACE) and MethylenetetrahydrofolateReductase Gene (MTHFR). J Ageing Nutr Health 2008, (Suppl 1):546.
72. Harmon DL, McMaster D, Shields DC, Whitehead AS, Rea IM. MTHFR thermolabile genotype frequencies and longevity in Northern Ireland. Atherosclerosis 1997, 131:137-138. 10.1016/S0021-9150(97)06096-6, 9180255.
73. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow R, Willett WC, Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996, 94:2410-2416.
74. Selhub J, Rosenberg IH. Public health significance of supplementation or fortification of grain products with folic acid. Food Nutr Bull 2008, 29(2 Suppl):S173-176.
75. Heijmans BT, Slagboom PE, Gussekloo J, Droog S, Lagaay AM, Kluft C, Knook DL, Westendorp RG. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. Am J Med Genet 2002, 107:201-208. 10.1002/ajmg.10142, 11807900.
76. Jablonka E, Raz G. Transgenerational epigenetic inheritance: prevalence, mechanisms, and implications for the study of heredity and evolution. Q Rev Biol 2009, 84:131-176. 10.1086/598822, 19606595.
77. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, Slagboom PE, Lumey LH. Persistent epigenetic differences associated with prenatal exposure to famine in humans. PNAS 2008, 105(44):17046-17049. 10.1073/pnas.0806560105, 2579375, 18955703.